Effects of Treadmill Versus Cycling Endurance Training in Patients With COPD
Effects of a Three Week Treadmill Versus Cycling Endurance Training on Balance, Gait Performance and Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease - a Pilot Study
1 other identifier
interventional
30
1 country
1
Brief Summary
Aim of this study is to investigate the effects of treadmill versus cycling endurance training on Balance, gait performance and exercise capacity in patients with severe chronic obstructive pulmonary disease. Patients will be recruited during a 3-week inpatient pulmonary rehabilitation program and will be randomized into one of two intervention groups. Walking intensity in the treadmill group will be set at 80 percent of the average speed of the 6-minute walking test. The cycling group will exercise at an intensity of 60 percent according to an Initial incremental cycling test. Patients will perform 5 to 6 training sessions per week. The total exercise duration will be progressively increased from 10 to 30 minutes. Walking or cycling intensity will also be progressively increased if perceived exertion during exercise is rated below 3 on the modified 10-point Borg scale.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable chronic-obstructive-pulmonary-disease
Started Mar 2017
Shorter than P25 for not_applicable chronic-obstructive-pulmonary-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 30, 2017
CompletedFirst Submitted
Initial submission to the registry
April 13, 2017
CompletedFirst Posted
Study publicly available on registry
April 19, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 27, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 27, 2017
CompletedFebruary 15, 2018
February 1, 2018
8 months
April 13, 2017
February 14, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in step symmetry during 20m walking
Patients walk 20m while wearing the Mc Roberts move test device (triaxial accelerometer) which performs a gait analysis
measurement on day 1 and 21
Secondary Outcomes (10)
Change in balance performance during semi-tandem stance
measurement on day 1 and 21
Change in balance performance during Romberg stance
measurement on day 1 and 21
Change in balance performance during single leg stance
measurement on day 1 and 21
Change in muscle power during counter movement jump
measurement on day 1 and 21
Change in 1 Minute sit to stand test
measurement on day 1 and 21
- +5 more secondary outcomes
Study Arms (2)
treadmill endurance training
ACTIVE COMPARATORcycling endurance training
ACTIVE COMPARATORInterventions
n = 15 patients with COPD. Walking intensity will be initially set at 80 percent of 6-minute Walking test Speed with progressive increase in Duration and intensity.
n=15 patients with COPD. Cycling intensity will initially be set at 60 percent of Peak work rate with progressive increase in Duration and intensity
Eligibility Criteria
You may qualify if:
- COPD Stage III or IV according to the global initiative for chronic obstructive lung disease
- impaired exercise capacity (6 Minute walk distance of less than 70% of the reference values from Troosters et al.)
You may not qualify if:
- acute, severe exacerbation of COPD
- carbon dioxide of more than 45 mmHg at rest
- any disabilities that prevent patient form walking or cycling
- Patient is not able to walk 20 meters without any aid (for example rollator)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Schoen Klinik Berchtesgadener Land
Schönau am Königssee, 83471, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head physican (department of pneumology)
Study Record Dates
First Submitted
April 13, 2017
First Posted
April 19, 2017
Study Start
March 30, 2017
Primary Completion
November 27, 2017
Study Completion
November 27, 2017
Last Updated
February 15, 2018
Record last verified: 2018-02